课题基金 / 基金详情

Monitoring the functional expression of multidrug resistance gene (MDR1) and study on potentiation of antitumor agent by MDR1 inhibitors in brain tumors.

Monitoring the functional expression of multidrug resistance gene (MDR1) and study on potentiation of antitumor agent by MDR1 inhibitors in brain tumors.
脑肿瘤中多药耐药基因(MDR1)功能表达的监测及MDR1抑制剂抗肿瘤药物的增效研究。
批准号:
11671351
负责人:
SASAJIMA Toshio
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

SASAJIMA Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this study is to explore whether ^<99m>Tc-MIBI is suitable to elucidate multidrug resistance and prediction of potentiation of antitumor agents by MDR1 inhibitors in malignant tumors.In order to induce and maintain multidrug resistance, tumor cells (RG2 and C6 gliomas, Walker 256 carcinoma : W256) were continuously incubated with low dose vincristine (VCR,1 ng/ml). MTT assay was performed following a 3-day exposure of various concentration of VCR (0.001-10 μg/ml) to assess the status of multidrug resistance. At a dose of 1 μg/ml of VCR, MTT assay demonstrated significant increase of surviving fractions in all VCR-resistant sublines (RG2R, C6R, W256R) as compared with those of drug-naive cell lines (RG2, C6, W256)(p<0.01). In all VCR-resistant sublines, RT-PCR revealed higher expression of MDR1 mRNA as compared with drug-naive cell lines. Vds of ^<99m>Tc-MIBI in VCR-resistant sublines expressing higher level of MDR1 mRNA was significantly lower than those of drug-naive cell l … More ines expressing lower levels of MDR1 mRNA (p<0.01). Vd of ^<99m>Tc-MIBI is negatively correlated with MDR1 mRNA expression (r=0.98, p<0.01) among drug-naive cell lines and VCR-resistant sublines. These findings indicated that the development of drug resistance was associated with enhanced ^<99m>Tc-MIBI extrusion.After 3-day pretreatment with MDR 1 inhibitors (verpamil, cyclosporin, FK506) at a concentration of 5 μM, surviving fractions of all VCR-resistant sublines significantly decreased as compared with those of non-treated VCR-resistant sublines. MTT assay revealed the enhancing effects on VCR cytotoxity following pretreatment with MDR 1 inhibitors. Vd of ^<99m>Tc-MIBI significantly increased after one-hour pretreatment with MDR 1 inhibitors at a concentration of 5 μM in all VCR-resistant sublines (p<0.01). These findings indicated that MIBI-dependent mechanisms allowing VCR extrusion were inhibited by MDR 1 inhibitors, which might have significant clinical implications such as ^<99m>Tc MIBI could be effective in monitoring therapies which act primarily on systems effected by MDR 1. ^<99m>Tc-MIBI SPECT is expected to provide more definitive criteria in monitoring multidrug resistance before and after chemotherapy in patients with malignant brain tumors. Less
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Satoh T, et al: "Relationships between ^<99m>Tc-MIBI uptake, tumor proliferation and MDRI mRNA expression in malignant tumors."J Cereb Blood Flow Metab. 19. S683 (1999)
Satoh T等人:“恶性肿瘤中^ 99m Tc-MIBI摄取、肿瘤增殖和MDRI mRNA表达之间的关系。”J Cereb Blood Flow Metab。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoh T, Sasajima T, Mineura K, Watanabe K, Mizoi K: "Relationships between ^<99m>Tc-MIBI uptake, tumor proliferation and MDRI mRNA expression in malignant tumors."J Cereb Blood Flow Metab. 19 (Suppl 1). 683 (1999)
Satoh T、Sasajima T、Mineura K、Watanabe K、Mizoi K:“恶性肿瘤中 ^<99m>Tc-MIBI 摄取、肿瘤增殖和 MDRI mRNA 表达之间的关系。”J Cereb Blood Flow Metab。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Experimental studies of synthesized amino acid analog anti-FACBC as imaging biomarker to monitor treatment response of glioblatomas to temozolomide therapy with interferon-. and bevacizumab
  • 批准号:
    22591602
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.75万
  • 财政年份:
    2010
  • 负责人:
    SASAJIMA Toshio
  • 依托单位:
Experimental studies of CD133(+) glioblastoma stem cells under normoxic and hypoxic conditions
  • 批准号:
    19591658
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    SASAJIMA Toshio
  • 依托单位:
Experimental studies on potentiation of antitumor agent by the second generation MDR1 inhibitors in malignant brain tumors : Monitoring multidrug resistance using ^<99m>Tc-MIBI
  • 批准号:
    16591426
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2004
  • 负责人:
    SASAJIMA Toshio
  • 依托单位:
海外基金